abrdn Healthcare Investors (HQH)
17.15
-0.57
(-3.22%)
USD |
NYSE |
Nov 21, 16:00
17.15
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| -- | -- | -- | -- |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | Upgrade | -- | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | Other |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| NASDAQ Biotechnology TR USD | 80.00% |
| S&P Composite 1500 Healthcare | 20.00% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Daniel Omstead | 23.10 yrs |
| Jason Akus | 0.62 yrs |
Performance Versus Category
Annual Total Returns Versus Peers
As of November 21, 2024.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | Other |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| NASDAQ Biotechnology TR USD | 80.00% |
| S&P Composite 1500 Healthcare | 20.00% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Daniel Omstead | 23.10 yrs |
| Jason Akus | 0.62 yrs |